Summary

Middle East Medical Device Testing Services Market Summary

The Middle East medical device testing services market size was estimated at USD 236.31 million in 2024 and is expected to grow at a CAGR of 7.93% from 2025 to 2023. The growth is driven by the tightening of regulatory frameworks such as Saudi Arabia’s SFDA Medical Devices Interim Regulation and the UAE’s updated conformity assessment procedures, which are increasing the volume and complexity of testing requirements. Expansion of regional healthcare infrastructure, particularly in Saudi Arabia and the UAE, is boosting the demand for certified and compliant medical devices.

In addition, rising healthcare infrastructure investments and increasing localization of manufacturing is also one of the factors contributing to the market growth. Countries such as Saudi Arabia and the UAE have been reinforcing device approval pathways through more stringent conformity assessments, pushing manufacturers to seek accredited testing for safety, efficacy, and biocompatibility. The expansion of domestic production capabilities in Saudi Arabia, Turkey, and Egypt is also amplifying the need for in-region testing to reduce turnaround times and comply with both domestic and export market requirements. Moreover, the growing prevalence of chronic diseases such as cardiovascular disorders and diabetes is spurring demand for advanced devices, which typically require complex analytical validation before market entry.

The Middle East medical device testing services industry’s growth is further driven by the region’s strategic role as a medical technology distribution hub for Africa and South Asia, making rapid and compliant testing essential for cross-border trade. Increasing adoption of cutting-edge technologies, including in-vitro diagnostics, wearable health monitors, and minimally invasive surgical devices, is raising the bar for performance and safety evaluation. Moreover, the emergence of specialized testing facilities within free zones, coupled with public-private partnerships, is streamlining regulatory approvals and fostering investor confidence. These factors position the Middle East as a growing center for medical device testing services, offering both regional and international players a faster route to commercialization.

Middle East Medical Device Testing Services Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East medical device testing services market report based on service, phase, and region:

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Biocompatibility Tests
o Cardiovascular Device's Biocompatibility Tests
o Orthopedic Device's Biocompatibility Tests
o Dental Implant Devices' Biocompatibility Tests
o Dermal Filler's Biocompatibility Tests
o General Surgery Implantation Devices Biocompatibility Tests
o Neurosurgical Implantation Devices Biocompatibility Tests
o Ophthalmic Implantation Device's Biocompatibility Tests
o Others
• Chemistry Test
o Chemical characterization (E&L)
o Analytical method development and validation
o Toxicological Risk Assessment and consulting
• Microbiology & Sterility Test
o Bioburden Determination
o Pyrogen & Endotoxin Testing
o Sterility Test & Validation
o Antimicrobial Testing
o Others
• Package Validation
• Phase Outlook (Revenue, USD Million, 2021 - 2033)
• Preclinical
o Large animal research
o Biocompatibility Tests
o Chemistry Test
o Microbiology & Sterility Test
o Small animal research
o Biocompatibility Tests
o Chemistry Test
o Microbiology & Sterility Test
• Clinical
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• Middle East
o Saudi Arabia
o UAE
o Kuwait
o Oman
o Qatar

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Phase
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Parent Market Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East Medical Device Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technological Advancements
3.4. Pricing Model Analysis
3.5. Market Analysis Tools
3.5.1. Porter’s Five Analysis
3.5.2. PESTEL by SWOT Analysis
Chapter 4. Middle East Medical Device Testing Services Market: Service Estimates & Trend Analysis
4.1. Middle East Medical Device Testing Services Market, By Service: Segment Dashboard
4.2. Middle East Medical Device Testing Services Market, By Service: Movement Analysis
4.3. Middle East Medical Device Testing Services Market Estimates & Forecasts, By Service, 2021 - 2033
4.4. Biocompatibility Tests
4.4.1. Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Cardiovascular Device's Biocompatibility Tests
4.4.2.1. Cardiovascular Device's Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Orthopedic Device's Biocompatibility Tests
4.4.3.1. Orthopedic Device's Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Dental Implant Devices' Biocompatibility Tests
4.4.4.1. Dental Implant Devices' Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Dermal Filler's Biocompatibility Tests
4.4.5.1. Dermal Filler's Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.6. General Surgery Implantation Devices Biocompatibility Tests
4.4.6.1. General Surgery Implantation Devices Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.7. Neurosurgical Implantation Devices Biocompatibility Tests
4.4.7.1. Neurosurgical Implantation Devices Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.8. Ophthalmic Implantation Device's Biocompatibility Tests
4.4.8.1. Ophthalmic Implantation Device's Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.9. Others
4.4.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Chemistry Test
4.5.1. Chemistry Test Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Chemical characterization (E&L)
4.5.2.1. Chemical Characterization (E&L) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Analytical method development and validation
4.5.3.1. Analytical Method Development and Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Toxicological Risk Assessment and consulting
4.5.4.1. Toxicological Risk Assessment and Consulting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Microbiology & Sterility Testing
4.6.1. Microbiology & Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Bioburden Determination
4.6.2.1. Bioburden Determination Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Pyrogen & Endotoxin Testing
4.6.3.1. Pyrogen & Endotoxin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Sterility Test & Validation
4.6.4.1. Sterility Test & Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Antimicrobial Testing
4.6.5.1. Antimicrobial Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Package Validation
4.7.1. Package Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Medical Device Testing Services Market: Phase Estimates & Trend Analysis
5.1. Middle East Medical Device Testing Services Market, By Phase: Segment Dashboard
5.2. Middle East Medical Device Testing Services Market, By Phase: Movement Analysis
5.3. Middle East Medical Device Testing Services Market Estimates & Forecasts, By Phase, 2021 - 2033
5.4. Preclinical
5.4.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Small Animals
5.4.2.1. Small Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.2. Biocompatibility Tests
5.4.2.2.1. Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.3. Chemistry Tests
5.4.2.3.1. Chemistry Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2.4. Microbiology & Sterility Tests
5.4.2.4.1. Microbiology & Sterility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Large Animals
5.4.3.1. Large Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.2. Biocompatibility Tests
5.4.3.2.1. Biocompatibility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.3. Chemistry Tests
5.4.3.3.1. Chemistry Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3.4. Microbiology & Sterility Tests
5.4.3.4.1. Microbiology & Sterility Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.4. Clinical
5.4.4.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Medical Device Testing Services Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Middle East
6.4.1. Middle East Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.2. Saudi Arabia
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. UAE
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Kuwait
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.5. Oman
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.6. Qatar
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Market Share Analysis, 2024
7.3. Company Profiles
7.3.1. SGS SA
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Laboratory Corporation of America Holdings
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Nelson Laboratories, LLC
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. TÜV SÜD
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Charles River Laboratories
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Element Minnetonka
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Eurofins Scientific
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Pace Analytical Services LLC
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Intertek Group Plc
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. North America Science Associates Inc. (NAMSA) (WuXi AppTec)
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of abbreviation
Table 2 Middle East Medical Device Testing Services Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
Table 3 Middle East Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 4 Middle East Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
Table 5 Saudi Arabia Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 6 Saudi Arabia Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
Table 7 UAE Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 8 UAE Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
Table 9 Kuwait Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 10 Kuwait Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
Table 11 Oman Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 12 Oman Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
Table 13 Qatar Medical Device Testing Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 14 Qatar Medical Device Testing Services Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Medical Device Testing Services Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Middle East Medical Device testing services market: Service outlook and key takeaways
Fig. 20 Middle East Medical device testing services market: Service movement analysis
Fig. 21 Biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Cardiovascular device's biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Orthopedic device's biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Dental Implant devices' biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Dermal fillers biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 General surgery implantation devices biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Neurosurgical implantation devices biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Ophthalmic implantation device's biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Others market estimates and forecasts, 2021 - 2033 (USD Million) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Chemistry test market estimates and forecasts, 2021 - 2033 (USD Million) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Chemical Characterization (E&L) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Analytical method development and validation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Toxicological risk assessment and consulting market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Microbiology & sterility test market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Bioburden determination market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Pyrogen & endotoxin testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Sterility test & validation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Antimicrobial testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Package validation market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Medical device testing services market: Phase outlook and key takeaways
Fig. 42 Medical device testing services market: Phase movement analysis
Fig. 43 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Large animal research market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Chemistry test market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Microbiology & sterility test market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Small animal research market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Biocompatibility tests market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Chemistry test market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Microbiology & sterility test market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Regional Marketplace: Key Takeaways
Fig. 54 Middle East medical device testing services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Saudi Arabia medical device testing services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 UAE medical device testing services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Kuwait medical device testing services market estimates and forecasts, 2021 - 2033, (USD Million)
Fig. 61 Oman medical device testing services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Qatar medical device testing services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key company categorization
Fig. 65 Service heat map analysis
Fig. 66 Strategic framework